JB/CALL/POLE GROU/21/0.125/21.06.24 | Market Closed - Swiss Exchange 11:20:00 2024-06-06 am EDT | ||
| 1.46 CHF | +0.69% |
|
| Current month | -6.41% | ||
| 1 month | +23.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 1.46 | +0.69% |
| 24-06-05 | 1.45 | +3.57% |
| 24-06-04 | 1.4 | +1.45% |
| 24-06-03 | 1.38 | -11.54% |
| 24-05-31 | 1.56 | +9.09% |
Delayed Quote Swiss Exchange
Last update June 06, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPGXJB | |
| ISIN | CH1276780124 |
| Date issued | 2023-07-21 |
| Strike | 21 CHF |
| Maturity | 2024-06-21 (15 Days) |
| Parity | 8 : 1 |
| Emission price | 0.51 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 1.61 CHF |
|---|---|
| Lowest since issue | 0.07 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.68% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
33.64
EUR
Average target price
25.12
EUR
Spread / Average Target
-25.31%
- Stock Market
- Warrants
- PPGXJB Warrant
